|
1
|
Lertkhachonsuk AA, Yip CH, Khuhaprema T,
Chen DS, Plummer M, Jee SH, Toi M and Wilailak S: Asian Oncology
Summit 2013: Cancer prevention in Asia: Resource-stratified
guidelines from the Asian Oncology Summit 2013. Lancet Oncol.
14:e497–e507. 2005. View Article : Google Scholar
|
|
2
|
Mohanty G and Ghosh SN: Risk factors for
cancer of cervix, status of screening and methods for its
detection. Arch Gynecol Obstet. 291:247–249. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ito Y: RUNX genes in development and
cancer: Regulation of viral gene expression and the discovery of
RUNX family genes. Adv Cancer Res. 99:33–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hug BA, Ahmed N, Robbins JA and Lazar MA:
A chromatin immunoprecipitation screen reveals protein kinase Cbeta
as a direct RUNX1 target gene. J Biol Chem. 279:825–830. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ito Y and Miyazono K: RUNX transcription
factors as key targets of TGF-beta superfamily signaling. Curr Opin
Genet Dev. 13:43–47. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bangsow C, Rubins N, Glusman G, Bernstein
Y, Negreanu V, Goldenberg D, Lotem J, Ben-Asher E, Lancet D,
Levanon D and Groner Y: The RUNX3 gene-sequence, structure and
regulated expression. Gene. 279:221–232. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Feng Q, Ji C, Liu X, Li L and Luo
J: RUNX3 plays an important role in mediating the BMP9-induced
osteogenic differentiation of mesenchymal stem cells. Int J Mol
Med. 40:1991–1999. 2017.PubMed/NCBI
|
|
8
|
Li QL, Ito K, Sakakura C, Fukamachi H,
Inoue Ki, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, et al: Causal
relationship between the loss of RUNX3 expression and gastric
cancer. Cell. 109:113–124. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen LF: Tumor suppressor function of
RUNX3 in breast cancer. J Cell Biochem. 113:1470–1477.
2012.PubMed/NCBI
|
|
10
|
Vogiatzi P, De Falco G, Claudio PP and
Giordano A: How does the human RUNX3 gene induce apoptosis in
gastric cancer? Latest data, reflections and reactions. Cancer Biol
Ther. 5:371–374. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee SH, Kim J, Kim WH and Lee YM: Hypoxic
silencing of tumor suppressor RUNX3 by histone modification in
gastric cancer cells. Oncogene. 15:184–194. 2009. View Article : Google Scholar
|
|
12
|
Suzuki M, Shigematsu H, Shames DS, Sunaga
N, Takahashi T, Shivapurkar N, Iizasa T, Frenkel EP, Minna JD,
Fujisawa T and Gazdar AF: DNA methylation-associated inactivation
of TGFbeta-related genes DRM/Gremlin, RUNX3 and HPP1 in human
cancers. Br J Cancer. 93:1029–1037. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nevadunsky NS, Barbieri JS, Kwong J,
Merritt MA, Welch WR, Berkowitz RS and Mok SC: RUNX3 protein is
overexpressed in human epithelial ovarian cancer. Gynecol Oncol.
112:325–330. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee CW, Chuang LS, Kimura S, Lai SK, Ong
CW, Yan B, Salto-Tellez M, Choolani M and Ito Y: RUNX3 functions as
an oncogene in ovarian cancer. Gynecol Oncol. 122:410–417. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsunematsu T, Kudo Y, Iizuka S, Ogawa I,
Fujita T, Kurihara H, Abiko Y and Takata T: RUNX3 has an oncogenic
role in head and neck cancer. PLoS One. 4:e58922009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kudo Y, Tsunematsu T and Takata T:
Oncogenic role of RUNX3 in head and neck cancer. J Cell Biochem.
112:387–393. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lai KW, Koh KX, Loh M, Tada K, Subramaniam
MM, Lim XY, Vaithilingam A, Salto-Tellez M, Iacopetta B and Ito Y:
MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric
cancer. Eur J Cancer. 46:1456–1463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng F, Wu J, Zhao S, Luo Q, Tang Q, Yang
L, Li L, Wu W and Hann SS: Baicalein increases the expression and
reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα
and MEK/ERK1/2 signaling pathways in human non-small cell lung
cancer cells. J Exp Clin Cancer Res. 34:412015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee YS, Lee JW, Jang JW, Chi XZ, Kim JH,
Li YH, Kim MK, Kim DM, Choi BS, Kim EG, et al: RUNX3 inactivation
is a crucial early event in the development of lung adenocarcinoma.
Cancer Cell. 24:603–616. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu SF, Zhu HC, Gu FH, Huang BY and Liu HY:
Characteristics of an established cervical carcinoma cell line
HCE1. Hunan Yi Ke Da Xue Xue Bao. 25:532–534. 2000.(In Chinese).
PubMed/NCBI
|
|
21
|
Ito K, Lim AC, Salto-Tellez M, Motoda L,
Osato M, Chuang LS, Lee CW, Voon DC, Koo JK, Wang H, et al: RUNX3
attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
Cancer Cell. 14:226–237. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang B, Du J, Li Y, Tang F, Wang Z and He
S: EZH2 elevates the proliferation of human cholangiocarcinoma
cells through the downregulation of RUNX3. Med Oncol. 31:2712014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Subramaniam MM, Chan JY, Yeoh KG, Quek T,
Ito K and Salto-Tellez M: Molecular pathology of RUNX3 in human
carcinogenesis. Biochim Biophys Acta. 1796:315–331. 2009.PubMed/NCBI
|
|
24
|
Chen F, Liu X, Bai J, Pei D and Zheng J:
The emerging role of RUNX3 in cancer metastasis (Review). Oncol
Rep. 35:1227–1236. 2016. View Article : Google Scholar : PubMed/NCBI
|
